Betta Pharmaceuticals Co., Ltd

Betta Pharmaceuticals Co., Ltd. (SZ300558), established in 2003 in Hangzhou, China, is one of the leading Chinese pharmaceutical companies dedicated to develop and commercialize innovative oncology products to meet high unmet medical needs. With over 1,300 employees in Hangzhou and Beijing, China, Bettas development capabilities range from small molecule and biologics discovery, clinical development, registration, manufacturing, sales and marketing. Bettas leading product icotinib (Conmana), the first innovative oncology product developed and commercially launched by a Chinese pharmaceutical company is the No.1-selling targeted therapy treating non-small cell lung cancer patients carrying EGFR mutations in China, having achieved 1.25 billion RMB annual...

Betta pharmaceuticals co., ltd operates in the Pharmaceutical manufacturing industry.

Betta pharmaceuticals co., ltd's revenue is 101m - 500m

Betta pharmaceuticals co., ltd has 11 - 50 employees.